| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 24.410 | 36.727 | 35.423 | 32.818 | 37.638 |
| Total Income - EUR | - | - | - | - | - | 24.410 | 36.727 | 35.423 | 32.818 | 37.638 |
| Total Expenses - EUR | - | - | - | - | - | 9.378 | 9.709 | 5.437 | 13.912 | 21.070 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 15.033 | 27.018 | 29.986 | 18.906 | 16.568 |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.788 | 26.651 | 29.083 | 18.584 | 15.461 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endoped Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 451 | 365 | 1.876 | 1.578 |
| Current Assets | - | - | - | - | - | 17.488 | 43.708 | 30.383 | 20.773 | 19.021 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 172 | 417 | 23.130 | 18.779 | 10.123 |
| Cash | - | - | - | - | - | 17.316 | 43.291 | 7.253 | 1.994 | 8.898 |
| Shareholders Funds | - | - | - | - | - | 15.120 | 41.435 | 29.131 | 18.633 | 15.510 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.368 | 2.723 | 1.616 | 4.017 | 5.097 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Endoped Srl